Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
Status:
Completed
Trial end date:
2018-05-17
Target enrollment:
Participant gender:
Summary
The objective of the trial is to investigate whether early treatment with oral valganciclovir
of infants with both congenital cytomegalovirus infection and sensorineural hearing loss can
prevent progression of hearing loss.
Phase:
Phase 3
Details
Lead Sponsor:
Dr. Ann C.T.M. Vossen
Collaborators:
Leiden University Medical Center Stichting Nuts Ohra